Back to Stocks

EHTH

eHealth, Inc.
6 filings tracked
healthcareinsurance brokerageSMALL ($300M-2B)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

eHealth is executing a high-conviction strategic pivot, intentionally trading top-line volume for sustainable profitability.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

Despite the narrative of a strategic recalibration, eHealth's financial results reveal a business in a precarious state of decline. Total revenue plummeted 22% year-over-year, driven by a significant drop in Medicare Advantage and individual-and-family plan approvals.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every EHTH filing.

Start Free Trial

Synthesis (Verdict & Resolution)

The Q1 2026 filing presents a stark contrast between operational discipline and fundamental business erosion. On one hand, management has successfully slashed marketing costs and improved unit economics, generating $35.8 million in operating cash flow despite a net loss. On the other hand, the 21% decline in approved members suggests that the 'strategic pivot' may be masking a loss of market share and a struggle to maintain growth in a volatile regulatory environment. Investors are now faced with a binary outcome: either the lifetime advisory model successfully transforms eHealth into a high-LTV recurring revenue business, or the company continues to shrink until its debt and preferred stock obligations become unsustainable. The resolution of the False Claims Act litigation and the company's ability to maintain its critical carrier relationships will be the primary determinants of its long-term viability.

Selected Quarter

Core Takeaway

eHealth is intentionally reducing member acquisition to fix unit economics, but is facing a significant top-line contraction and legal headwinds.

Investor Lens

The trade-off between short-term revenue growth and long-term unit economics, balanced against escalating legal and debt risks.

Watch Next

Q2 2026 results to see the initial impact of the lifetime advisory model and any updates on the False Claims Act litigation.

View Full SEC Report

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)-0.27Q2 '26 (10-Q)

Signal Timeline

Active Filters:Quarter: Q2 '26 (10-Q)
bearishMay 7

Total revenue declined 22% year-over-year to $88.0 million.

earnings miss
70%
bullishMay 7

Reduced total acquisition cost per MA-equivalent member by 10%.

margin expansion
40%
neutralMay 7

Entered into a new $125 million asset-based revolving credit facility.

debt restructure
50%
bearishMay 7

Facing a qui tam action under the Federal False Claims Act.

regulatory action
80%
bearishMay 7

Total revenue declined 22% year-over-year to $88.0 million.

earnings miss
70%
bullishMay 7

Reduced total acquisition cost per MA-equivalent member by 10%.

margin expansion
40%
neutralMay 7

Entered into a new $125 million asset-based revolving credit facility.

debt restructure
50%
bearishMay 7

Facing a qui tam action under the Federal False Claims Act.

regulatory action
80%
bearishMay 7

Total revenue declined 22% year-over-year to $88.0 million.

earnings miss
70%
bullishMay 7

Reduced total acquisition cost per MA-equivalent member by 10%.

margin expansion
40%
neutralMay 7

Entered into a new $125 million asset-based revolving credit facility.

debt restructure
50%
bearishMay 7

Facing a qui tam action under the Federal False Claims Act.

regulatory action
80%
bearishMay 7

Total revenue declined 22% year-over-year to $88.0 million.

earnings miss
70%
bullishMay 7

Reduced total acquisition cost per MA-equivalent member by 10%.

margin expansion
40%
neutralMay 7

Entered into a new $125 million asset-based revolving credit facility.

debt restructure
50%
bearishMay 7

Facing a qui tam action under the Federal False Claims Act.

regulatory action
80%
bearishMay 7

Total revenue declined 22% year-over-year to $88.0 million.

earnings miss
70%
bullishMay 7

Reduced total acquisition cost per MA-equivalent member by 10%.

margin expansion
40%
neutralMay 7

Entered into a new $125 million asset-based revolving credit facility.

debt restructure
50%
bearishMay 7

Facing a qui tam action under the Federal False Claims Act.

regulatory action
80%
bearishMay 7

Total revenue declined 22% year-over-year to $88.0 million.

earnings miss
70%
bullishMay 7

Reduced total acquisition cost per MA-equivalent member by 10%.

margin expansion
40%
neutralMay 7

Entered into a new $125 million asset-based revolving credit facility.

debt restructure
50%
bearishMay 7

Facing a qui tam action under the Federal False Claims Act.

regulatory action
80%

Filing History

10-QMay 7, 2026
Expand Sequence

The Q1 2026 filing presents a stark contrast between operational discipline and fundamental business erosion. On one hand, management has successfully slashed marketing costs and improved unit economics, generating $35.8 million in operating cash flow despite a net loss. On the other hand, the 21% decline in approved members suggests that the 'strategic pivot' may be masking a loss of market share and a struggle to maintain growth in a volatile regulatory environment. Investors are now faced with a binary outcome: either the lifetime advisory model successfully transforms eHealth into a high-LTV recurring revenue business, or the company continues to shrink until its debt and preferred stock obligations become unsustainable. The resolution of the False Claims Act litigation and the company's ability to maintain its critical carrier relationships will be the primary determinants of its long-term viability.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.